On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< XENE Xenon Pharmaceuticals - 06/22/22
- Xenon provides update on additional data from XEN1101 program
- 06/21/22
- Xenon Pharmaceuticals on track to initiate XEN1101 Phase 3 program in 2H22
- 05/03/22
- Xenon Pharmaceuticals announces initiation of Phase 3 trial of XEN1101
- 01/19/22
- Xenon Pharmaceuticals' flunarizine granted FDA orphan designation
- 06/23/22
- Uber CEO says 'zero truth' to Bloomberg report on Indian ride-hailing business
- 06/21/22
- Uber announces availability of UberX Share carpooling
- 06/09/22
- Uber CEO: Business is booming
- 06/08/22
- Uber debuts Nationwide shipping, enables 'cross-country cravings' from US cities
- 06/16/22
- T-Mobile to offer free in-flight connectivity on select flights starting June 21
- 06/15/22
- United Airlines debuts plant-based menu items from Impossible Foods
- 06/08/22
- United Airlines announces nonstop service between San Francisco and Brisbane
- 06/06/22
- United Airlines director buys $2.24M in common stock
- $143.06 /
+15.715 (+12.34%) - 06/08/22
- Snowflake CEO: Our customers are not falling off a cliff
- 06/07/22
- Snowflake launches new Cybersecurity workload
- 05/30/22
- Fly Intel: Top five weekend stock stories
- 05/26/22
- Snowflake falls -12.8%
- $10.84 /
+1.945 (+21.87%) - 06/23/22
- Radius to be acquired by Gurnet Point, Patient Square for $10 per share plus CVR
- 06/22/22
- Menarini, Radius Health submit NDA to FDA for elacestrant
- 06/16/22
- Rubric Capital says Radius board aware of other shareholders' concerns
- 06/13/22
- Velan Capital : Radius Health board 'applying a flawed definition of activism'
- 04/11/22
- RedHill Bio: Opaganib shows 'potent in vitro efficacy' against Omicron variant
- 04/11/22
- RedHill Biopharma announces Omicron inhibition with opaganib
- 04/11/22
- RedHill Biopharma announces opaganib observed to have efficacy against omicron
- 03/15/22
- RedHill Biopharma announces license agreement with Kukbo
- 05/31/22
- Rite Aid, Homeward announce partnership to serve rural areas
- 05/03/22
- Rite Aid and Block unit Afterpay partner to offer BNPL on everyday items
- 04/21/22
- Spear Point says 'would love to hear' Rite Aid plan superior to firm's proposal
- 04/21/22
- Rite Aid falls -8.7%
- 06/23/22
- uniQure provides update on low-dose cohort in Phase I/II trial of AMT-130
- 06/22/22
- uniQure announces grant equity awards to 32 new employees
- 05/24/22
- uniQure announces FDA accepts priority review BLA for etranacogene dezaparvovec
- 05/11/22
- uniQure announces inducement grants under Nasdaq listing rule 5635(c)(4)
- 06/23/22
- Bang Energy announces transition from PepsiCo
- 05/19/22
- PepsiCo director sells $2.38M in common stock
- 05/12/22
- PepsiCo taps Billtrust's ACA solution for hard Mountain Dew distribution
- 04/26/22
- PepsiCo: North American convenient foods, beverage business 'resilient'
- $51.80 /
+6.305 (+13.86%) - 06/23/22
- Novavax' COVID-19 vaccine granted emergency use authorization in Taiwan
- 06/23/22
- Novavax says Nuvaxovid recommended for expanded conditional authorization in EU
- 06/23/22
- EMA recommends extending authorization of Nuvaxovid for ages 12 to 17
- 06/13/22
- Novavax: Australian TGA grants provisional registration of Nuvaxovid for age 18+
- 05/13/22
- Soros buys Lucid, exits GM in Q1
- 03/21/22
- Nike says nearly all of supplier base is operational without restriction
- 03/21/22
- Nike jumps over 5% to $137.65 after Q3 earnings beat
- 03/21/22
- Nike reports Q3 Nike Direct growth 17%
- 06/22/22
- Magnite on watch following WSJ report on Netflix ad partnership considerations
- 06/14/22
- Netflix working on 'Squid Game' reality competition series
- 06/13/22
- Netflix announces 'Squid Game' coming back for season 2
- 06/08/22
- Roku jumps 6% to $99.08 after Insider report of internal Netflix buyout talk
- 06/23/22
- Mullen Automotive issues shareholder update
- 06/22/22
- Mullen Automotive announces filing of US, international patent applications
- 06/21/22
- Mullen Automotive extends maturity of senior secured convertible note
- 06/06/22
- Mullen Automotive to be added to Russell 2000, 3000 Indexes
- $143.44 /
+7.395 (+5.44%) - 06/22/22
- Moderna: mRNA-1273.214 shows antibody response against Omicron subvariants
- 06/21/22
- Moderna to bring mRNA innovation to U.K.
- 06/19/22
- Walgreens now providing Pfizer, Moderna COVID vaccines to children ages 3+
- 06/19/22
- CDC recommends Pfizer, Moderna vaccines for children under six
- 06/23/22
- FDA denies authorization to market JUUL products
- 06/23/22
- FDA denies authorization to market JUUL products
- 04/28/22
- FDA proposes rules prohibiting menthol cigarettes and flavored cigars
- 04/13/22
- JUUL to pay Washington $22.5M over advertising practices
- 06/15/22
- Crypto names fall again as bitcoin extends decline to $20,000
- 06/13/22
- Crypto names down sharply as bitcoin falls below $24,000
- 06/09/22
- Marathon Digital increased total bitcoin holdings to 9,941 BTC as of June 1
- 06/07/22
- Crypto stocks slip as bitcoin falls back below $30,000
- 06/12/22
- Fly Intel: Top five weekend stock stories
- 06/08/22
- Astronics awarded contract by Southwest Airlines to provide In-Seat Power
- 06/03/22
- Southwest reports tentative pact with AMFA for Aircraft Appearance Technicians
- 06/01/22
- Southwest announces investment into SAFFiRE Renewables
- 06/22/22
- KB Home jumps 4% to $27.75 after Q2 earnings beat
- 06/22/22
- KB Home reports ending backlog value up 43% at $6.12B
- 06/22/22
- KB Home reports Q2 average selling prices up 21% at $494.3K
- 05/13/22
- KB Home announces grand opening of Silverado
- $388.96 /
+28.03 (+7.77%) - 04/28/22
- FactSet raises quarterly dividend 8.5% to 89c per share
- 04/27/22
- FactSet says Chief Technology and Content Officer Fernandez to leave
- 02/23/22
- FactSet, BlackRock enter multi-year partnership for Portware EMS capabilities
- 02/15/22
- FactSet announces commencement of senior notes offering
- 06/23/22
- eBay drops 2.4% in premarket trading as Morgan Stanley assumes with Underweight
- 06/22/22
- eBay acquires NFT marketplace KnownOrigin, terms not disclosed
- 06/16/22
- eBay announces launch of eBay Live
- 06/07/22
- eBay launches eBay vault for trading cards
- $115.64 /
+0.425 (+0.37%) - 06/23/22
- Darden announces new $1B share repurchase program
- 06/23/22
- Darden reports Q4 blended same-restaurant sales up 11.7%
- 06/23/22
- Darden raises quarterly dividend 10% to $1.21 per share
- 03/24/22
- Darden reports Q3 blended same-restaurant sales up 38.1%
- 06/23/22
- Appeals court vacates willful infringement ruling against Cisco
- 06/15/22
- Cisco announces launches of Panoptica and Calisti API-first solutions
- 06/13/22
- Cisco, Emtrain announce partnership
- 06/08/22
- Cisco CEO: The situation in China is temporary
- 05/11/22
- CycleBar partners with CELSIUS 'to fuel riders across the country'
- 04/18/22
- Celsius Holdings CFO Carballo to retire; Jarrod Langhans named CFO
- 12/29/21
- Celsius Holdings CEO sells $1.5M in common stock
- 06/15/22
- MicroStrategy CEO says strategy is to be 'levered, long bitcoin'
- 06/15/22
- MicroStrategy CEO says excess cash will be used to buy more bitcoin
- 06/15/22
- MicroStrategy CEO says 98% of world doesn't understand digital scarcity concept
- 06/15/22
- MicroStrategy CEO says balance sheet 'fortress,' margin 'well managed'
- 06/13/22
- Binance CEO says Bitcoin withdrawals temporarily paused on platform
- 05/19/22
- Could crypto crash be good for U.S. economy? Probably.
- 05/12/22
- Terra developers say blockchain was officially halted
- 06/23/22
- Acuity Brands falls -5.2%
- 04/07/22
- Acuity Brands appoints Sankpal as SVP, Growth, Transformation
- 02/03/22
- Acuity Brands announces new initiative planned to reduce paper waste
- 01/12/22
- Acuity Brands expanding collaboration with Microsoft
- 05/26/22
- Broadcom deal for VMware provides for 'go-shop' provision
- 05/26/22
- Broadcom board authorizes new $10B share repurchase program
- 05/26/22
- Broadcom to buy VMware for about $61B in cash and stock or $138.23 per share
- 05/26/22
- Broadcom to acquire VMware for about $61B in cash and stock
- 06/23/22
- Amyris begins fermentation at new plant in Barra Bonita, Brazil
- 04/11/22
- Amyris begins commissioning of new fermentation plant in Barra Bonita, Brazil
- 01/24/22
- Amyris to acquire Menolabs, terms not disclosed
- 06/23/22
- Johnson Controls, Accenture partner on OpenBlue Innovation Centers
- 06/23/22
- Accenture raises FY22 negative FX impact view to 4.5% from 3%
- 06/23/22
- Accenture sees FY22 operating cash flow $8.7B-$9.2B
- 06/06/22
- Accenture acquires technology consultancy and managed services provider Advocate
- 06/24/22 Piper Sandler
- Accenture price target lowered to $305 from $368 at Piper Sandler
- 06/17/22 Deutsche Bank
- Accenture price target lowered to $364 from $440 at Deutsche Bank
- 06/15/22 Cowen
- Accenture price target lowered to $330 from $375 at Cowen
- 06/14/22 Morgan Stanley
- Accenture price target lowered to $390 from $480 at Morgan Stanley
- $10.84 /
+1.945 (+21.87%) - 06/08/22 BofA
- Radius Health upgraded to Neutral at BofA with bear thesis 'played out'
- 06/08/22 BofA
- Radius Health upgraded to Neutral from Underperform at BofA
- 05/23/22 SVB Leerink
- Radius Health initiated with a Market Perform at SVB Leerink
- 12/23/21 Stifel
- New Radius' Tymlos label offers slight expansion potential, says Stifel
- 06/24/22 Morgan Stanley
- Altria Group upgraded to Equal Weight from Underweight at Morgan Stanley
- 06/22/22 Goldman Sachs
- Altria selloff overdone on potential FDA action on JUUL, says Goldman Sachs
- 06/22/22 Stifel
- Potential ban of JUUL vapor products 'clear negative' for Altria, says Stifel
- 06/22/22 Jefferies
- FDA lowered nicotine rule likely to take many years to implement, says Jefferies
- $51.80 /
+6.305 (+13.86%) - 06/08/22 B. Riley
- B. Riley sees front line status for Novavax vaccine as mRNA alternative
- 06/08/22 Cowen
- Novavax positive advisory vote removes major overhang, says Cowen
- 06/08/22 Cantor Fitzgerald
- Novavax price target raised to $168 from $146 at Cantor Fitzgerald
- 06/08/22 H.C. Wainwright
- H.C. Wainwright expects 'significant market share' for Novavax vaccine
- $143.44 /
+7.395 (+5.44%) - 06/14/22 Piper Sandler
- Piper Sandler confident in positive VRBPAC opinion for Moderna's SpikeVax
- 06/13/22 Morgan Stanley
- Moderna pediatric EUA vaccine briefing docs 'clean,' says Morgan Stanley
- 05/17/22 Piper Sandler
- Moderna price target lowered to $214 from $348 at Piper Sandler
- 04/20/22 Piper Sandler
- Piper says 'do not be fooled,' Arcturus Phase 3 shows strong vaccine efficacy
- 06/23/22 Morgan Stanley
- eBay assumed with an Underweight at Morgan Stanley
- 06/09/22 Goldman Sachs
- eBay downgraded to Sell from Neutral at Goldman Sachs
- 06/01/22 JMP Securities
- eBay resumed with a Market Perform at JMP Securities
- 05/23/22 Bernstein
- eBay initiated with a Market Perform at Bernstein
- $143.06 /
+15.715 (+12.34%) - 06/23/22 JPMorgan
- Snowflake upgraded to Overweight from Neutral at JPMorgan
- 06/16/22 Piper Sandler
- Snowflake has 'multi-billion growth potential,' says Piper Sandler
- 06/15/22 Canaccord
- Snowflake upgraded to Buy at Canaccord following pullback
- 06/15/22 JPMorgan
- Snowflake price target lowered to $165 from $200 at JPMorgan
- 06/23/22 Raymond James
- Southwest upgraded to Strong Buy from Outperform at Raymond James
- 06/23/22 Raymond James
- Southwest upgraded to Strong Buy from Outperform at Raymond James
- 06/22/22 Citi
- Citi says this is not 2020 or 2008 for airline stocks
- 05/11/22 William Blair
- ViaSat deal with Southwest 'solidifies industry dominance,' says William Blair
- 06/23/22 William Blair
- William Blair downgrades Acuity Brands after survey points to weaker demand
- 06/23/22 William Blair
- Acuity Brands downgraded to Market Perform from Outperform at William Blair
- 06/17/22 Baird
- Acuity Brands price target lowered to $188 from $210 at Baird
- 04/06/22 Wells Fargo
- Acuity Brands price target lowered to $200 from $237 at Wells Fargo
- 06/23/22 B. Riley
- Marathon Digital downgraded to Neutral at B. Riley amid sharp decline in Bitcoin
- 06/23/22 B. Riley
- Marathon Digital downgraded to Neutral from Buy at B. Riley
- 06/03/22 Chardan
- Marathon Digital initiated with a Buy at Chardan
- 06/03/22 BTIG
- Marathon Digital price target lowered to $16 from $50 at BTIG
- 06/13/22 Morgan Stanley
- Ethereum weakening faster than bitcoin, says Morgan Stanley
- 06/07/22 Benchmark
- Benchmark starts Canaan with Buy as 'indirect' bitcoin growth play
- 06/03/22 BTIG
- Riot Blockchain price target lowered to $15 from $50 at BTIG
- 05/19/22 Goldman Sachs
- Any drag on spending from lower cryptocurrency prices 'very small,' says Goldman
- 05/10/22 Morgan Stanley
- $28,000 a technical level to watch for Bitcoin, says Morgan Stanley
- 06/24/22 Wolfe Research
- Uber price target lowered to $27 from $30 at Wolfe Research
- 06/16/22 Mizuho
- Uber hits 'speed bump' in Massachusetts, says Mizuho
- 06/09/22 Goldman Sachs
- Uber price target lowered to $45 from $55 at Goldman Sachs
- 06/08/22 Barclays
- Barclays ups Uber target, says time to revisit long thesis
- 05/27/22 RBC Capital
- VMware downgraded to Sector Perform from Outperform at RBC Capital
- 05/27/22 Mizuho
- Broadcom price target raised to $725 from $700 at Mizuho
- 05/27/22 KeyBanc
- Broadcom price target raised to $780 from $720 at KeyBanc
- 05/27/22 KeyBanc
- VMware downgraded to Sector Weight from Overweight at KeyBanc
- 06/23/22 Citi
- Citi adds AutoZone, Thermo Fisher, Ionis to 'Focus List'
- 06/23/22 Raymond James
- United Airlines price target lowered to $48 from $62 at Raymond James
- 05/06/22 Wolfe Research
- United Airlines upgraded to Peer Perform from Underperform at Wolfe Research
- 05/20/22 Morgan Stanley
- Cisco price target lowered to $46 from $59 at Morgan Stanley
- 05/19/22 Jefferies
- Cisco price target lowered to $52 from $65 at Jefferies
- 05/19/22 Evercore ISI
- Cisco price target lowered to $50 from $62 at Evercore ISI
- 05/19/22 BofA
- Cisco price target lowered to $52 from $62 at BofA
- 06/23/22 Cowen
- Nike price target lowered to $133 from $139 at Cowen
- 06/23/22 Deutsche Bank
- Nike price target lowered to $152 from $175 at Deutsche Bank
- 06/23/22 Credit Suisse
- Nike price target lowered to $130 from $165 at Credit Suisse
- 06/22/22 BTIG
- BTIG sees risk to Nike Q4 results and FY23 outlook
- 06/23/22 BofA
- Netflix price target lowered to $196 at BofA after streaming survey
- 06/21/22 Truist
- Magnite well positioned to partner with Netflix, says Truist
- 06/21/22 Stifel
- Netflix price target lowered to $240 from $300 at Stifel
- 06/14/22 Benchmark
- Benchmark downgrades Netflix back to Sell after 'premature' upgrade
- 05/05/22 Stifel
- uniQure price target lowered to $37 from $66 at Stifel
- 04/13/22 Truist
- uniQure price target lowered to $51 from $90 at Truist
- 03/30/22 Chardan
- uniQure price target lowered to $65 from $95 at Chardan
- 03/17/22 UBS
- uniQure upgraded to Buy from Neutral at UBS
- 05/25/22 Piper Sandler
- Amyris initiated with a Neutral at Piper Sandler
- 05/13/22 HSBC
- Amyris earnings selloff overdone, says HSBC
- 03/02/22 Cowen
- Amyris assumed with an Outperform at Cowen
- 11/09/21 Roth Capital
- Amyris price target lowered to $15 from $22 at Roth Capital
- 06/23/22 Stifel
- PepsiCo/Bang announcement 'positive' for Monster, other brands, says Stifel
- 06/10/22 Stifel
- Celsius Holdings price target raised to $77 from $67 at Stifel
- 05/11/22 B. Riley
- Celsius Holdings price target lowered to $100 from $115 at B. Riley
- 05/11/22 Maxim
- Celsius Holdings upgraded to Buy at Maxim after Q1 'triple beat'
- 06/21/22 UBS
- PepsiCo price target lowered to $182 from $190 at UBS
- 04/27/22 Guggenheim
- PepsiCo price target raised to $193 from $188 at Guggenheim
- 04/27/22 JPMorgan
- PepsiCo price target raised to $186 from $183 at JPMorgan
XENE Xenon Pharmaceuticals - 11/11/21 SVB Leerink
- Xenon Pharmaceuticals price target raised to $40 from $34 at SVB Leerink
- 10/28/21 RBC Capital
- Xenon Pharmaceuticals initiated with an Outperform at RBC Capital
- 10/06/21 Wedbush
- Wedbush remains bullish on Xenon as financing gives firepower to advance XEN1101
- 10/04/21 Jefferies
- Jefferies ups Xenon target to $50 after 'home run' epilepsy data
- 06/03/22 Deutsche Bank
- Rite Aid price target raised to $4 from $2 at Deutsche Bank
- 04/21/22 Deutsche Bank
- Deutsche Bank says 'just stop' with the Rite Aid takeover talk
- 04/18/22 Deutsche Bank
- Rite Aid price target raised to $2 from $1 at Deutsche Bank
- 04/07/22 Deutsche Bank
- Deutsche downgrades Rite Aid to Sell with $1 target into Q4 results
- $115.64 /
+0.425 (+0.37%) - 06/24/22 Wedbush
- Darden price target lowered to $122 from $140 at Wedbush
- 06/24/22 Piper Sandler
- Darden price target lowered to $150 from $153 at Piper Sandler
- 06/24/22 Barclays
- Darden price target lowered to $130 from $135 at Barclays
- 06/23/22 Stifel
- Darden price target lowered to $135 from $160 at Stifel
- 06/23/22 Evercore ISI
- KB Home price target raised to $50 from $46 at Evercore ISI
- 06/23/22 Wedbush
- KB Home price target lowered to $60 from $73 at Wedbush
- 06/16/22 UBS
- KB Home price target lowered to $45 from $66 at UBS
- 06/08/22 Barclays
- KB Home price target lowered to $44 from $47 at Barclays
- $388.96 /
+28.03 (+7.77%) - 06/24/22 Barclays
- FactSet price target lowered to $440 from $550 at Barclays
- 06/23/22 Stifel
- Not clear why FactSet adjusted EPS guidance wasn't lifted, says Stifel
- 06/17/22 Deutsche Bank
- FactSet price target lowered to $402 from $468 at Deutsche Bank
- 04/06/22 Deutsche Bank
- FactSet price target raised to $468 from $453 at Deutsche Bank
- 12/01/21 BTIG
- RedHill Biopharma price target lowered to $10 from $16 at BTIG
- 11/18/21
- RedHill Biopharma files to sell common stock, no amount given
- 09/15/21 BTIG
- RedHill Biopharma price target lowered to $16 from $24 at BTIG
- 09/15/21 H.C. Wainwright
- RedHill Biopharma price target lowered to $21 from $23 at H.C. Wainwright
XENE Xenon Pharmaceuticals - 05/10/22
- Xenon Pharmaceuticals reports Q1 EPS (35c), consensus (41c)
- 05/04/22
- Uber reports Q1 EPS ($3.04), consensus (24c)
- 02/09/22
- Uber reports Q4 EPS 44c, consensus (35c)
- 02/09/22
- Uber reports Q4 revenue $5.78B, consensus $5.34
- 02/09/22
- Notable companies reporting after market close
- 04/20/22
- United Airlines reports Q1 adjusted EPS ($4.24), consensus ($4.21)
- 04/20/22
- Notable companies reporting after market close
- 03/15/22
- United Airlines sees Q1 capacity down approximately 19%
- 01/19/22
- United Airlines sees FY22 capacity down vs 2019
- $143.06 /
+15.715 (+12.34%) - 05/25/22
- Snowflake reports Q1 EPS (53c), consensus 1c
- 05/25/22
- Notable companies reporting after market close
- 03/02/22
- Snowflake sees FY23 product revenue $1.88B-$1.9B
- 03/02/22
- Snowflake reports Q4 EPS (43c), consensus 3c
- $10.84 /
+1.945 (+21.87%) - 05/05/22
- Radius Health sees 2022 TYMLOS net revenue $232M
- 05/05/22
- Radius Health reports Q1 EPS (39c), consensus (21c)
- 02/24/22
- Radius Health reports Q4 adjusted EPS (5c), consensus (18c)
- 02/24/22
- Radius Health sees 2022 Tymlos revenue of $232M
- 06/23/22
- RedHill Biopharma reports Q1 EPS (3c), consensus (23c)
- 03/17/22
- RedHill Biopharma reports Q4 revenue $22.1M, consensus $24.08M
- 02/17/22
- RedHill Biopharma sees Q4 revenue $22M-$24M, consensus $24.08M
- 06/23/22
- Rite Aid cuts FY23 adjusted EPS view to ($1.19)-(66c) from ($1.06)-(53c)
- 06/23/22
- Rite Aid reports Q1 adjusted EPS (60c), consensus (70c)
- 04/14/22
- Rite Aid sees FY23 adjusted EPS ($1.06)-(53c)
- 04/14/22
- Rite Aid reports Q4 EPS ($1.63) vs. (34c) last year
- 05/02/22
- uniQure reports Q1 EPS ($1.00), consensus (93c)
- 02/25/22
- uniQure reports 2021 EPS $7.04, consensus $6.20
- 04/26/22
- PepsiCo cuts FY22 core EPS view to $6.63 from $6.67, consensus $6.65
- 04/26/22
- PepsiCo reports Q1 core EPS $1.29, consensus $1.23
- 04/25/22
- Notable companies reporting before tomorrow's open
- $51.80 /
+6.305 (+13.86%) - 05/09/22
- Novavax backs FY22 revenue view $4B-$5B, consensus $4.49B
- 05/09/22
- Novavax reports Q1 EPS $2.56, consensus $2.69
- 02/28/22
- Novavax sees FY22 revenue $4.0B-$5.0B, consensus $4.7B
- 02/28/22
- Novavax reports Q4 EPS ($11.18), consensus ($1.80)
- 03/21/22
- Nike backs FY22 revenue view up mid-single digits, consensus $46.9B
- 03/21/22
- Nike reports Q3 EPS 87c, consensus 71c
- 03/21/22
- Notable companies reporting after market close
- 04/19/22
- Netflix sees Q2 EPS $3.00, consensus $3.01
- 04/19/22
- Netflix reports Q1 EPS $3.53, consensus $2.90
- 04/19/22
- Notable companies reporting after market close
- 01/20/22
- Netflix sees Q1 EPS $2.86, consensus $3.45
- $143.44 /
+7.395 (+5.44%) - 05/04/22
- Moderna reports Q1 GAAP EPS $8.58, consensus $5.21
- 05/03/22
- Notable companies reporting before tomorrow's open
- 02/24/22
- Moderna reports Q4 GAAP EPS $11.29, consensus $9.90
- 05/19/22
- Altria Group backs FY22 adjusted EPS view $4.79-$4.93, consensus $4.86
- 04/28/22
- Altria Group backs FY22 adjusted EPS $4.79-$4.93, consensus $4.84
- 04/28/22
- Altria Group reports Q1 adjusted EPS $1.12, consensus $1.18
- 04/27/22
- Notable companies reporting before tomorrow's open
- 03/01/22
- Marathon Digital reports Q4 EPS 36c, consensus 34c
- 05/26/22
- Southwest raises Q2 operating revenue growth view
- 04/28/22
- Southwest backs FY22 CapEx view of $5B
- 04/28/22
- Southwest sees Q2 revenue up 8%-12%, consensus $5.61B
- 04/28/22
- Southwest reports Q1 adjusted EPS (32c), consensus (30c)
- 06/22/22
- KB Home reports Q2 EPS $2.32, consensus $2.01
- 06/22/22
- Notable companies reporting after market close
- 03/23/22
- KB Home sees FY22 housing revenue $7.2B-$7.6B
- 03/23/22
- KB Home reports Q1 EPS $1.47, consensus $1.56
- $388.96 /
+28.03 (+7.77%) - 06/23/22
- FactSet reaffirms FY23 adjusted EPS $12.75-$13.15, consensus $13.02
- 06/23/22
- FactSet reports Q3 adjusted EPS $3.76, consensus $3.23
- 03/24/22
- FactSet raises 2022 adjusted EPS view to $12.75-$13.15 from $12.00-$12.30
- 03/24/22
- FactSet reports Q2 adjusted EPS $3.27, consensus $2.97
- 05/04/22
- eBay cuts FY22 adj. EPS view to $3.90-$4.10 from $4.20-$4.40
- 05/04/22
- eBay sees Q2 adjusted EPS 87c-91c, consensus $1.01
- 05/04/22
- eBay reports Q1 adjusted EPS $1.05, consensus $1.03
- 05/04/22
- Notable companies reporting after market close
- $115.64 /
+0.425 (+0.37%) - 06/23/22
- Darden sees FY23 diluted cont ops EPS $7.40-$8.00, consensus $8.15
- 06/23/22
- Darden reports Q4 EPS $2.24, consensus $2.21
- 05/18/22
- Cisco cuts FY22 adjusted EPS view to $3.29-$3.37 from $3.41-$3.46
- 05/18/22
- Cisco sees Q4 adjusted EPS 76c-84c, consensus 92c
- 05/18/22
- Cisco reports Q3 adjusted EPS 87c, consensus 86c
- 05/18/22
- Notable companies reporting after market close
- 05/10/22
- Celsius Holdings reports Q1 EPS 9c, consensus 3c
- 03/01/22
- Celsius Holdings reports preliminary Q4 EPS 15c, consensus 4c
- 03/01/22
- Celsius Holdings reports preliminary Q4 revenue $104.3M, consensus $92.09M
- 04/05/22
- Acuity Brands reports Q2 adjusted EPS $2.57, consensus $2.37
- 01/07/22
- Acuity Brands reports Q1 adjusted EPS $2.85, consensus $2.41
- 01/07/22
- Acuity Brands reports Q1 diluted EPS $2.46, consensus $2.41
- 05/26/22
- Broadcom sees Q3 revenue $8.4B, consensus $8.01B
- 05/26/22
- Broadcom reports Q2 adjusted EPS $9.07, consensus $8.70
- 03/03/22
- Broadcom sees Q2 revenue $7.9B, consensus $7.43B
- 03/03/22
- Broadcom reports Q1 adjusted EPS $8.39, consensus $8.08
- 06/23/22
- Accenture sees Q4 revenue $15B-$15.5B, consensus $14.83B
- 06/23/22
- Accenture narrows FY22 EPS view to $10.61-$10.70 from $10.61-$10.81
- 06/23/22
- Accenture reports Q3 EPS $2.79, consensus $2.72
- 06/22/22
- Notable companies reporting before tomorrow's open
|